|
Cellectar Newsroom
Find the latest information about Cellectar.
Cellectar, Inc. Begins GMP Production
August 18, 2008
Radiopharmaceutical production facility to support clinical development for lead drug candidate and other molecules.
Cellectar Raises $13 Million in Private Offering
January 8, 2008
Cellectar announces completion of a $13 million private offering for phase 1 clinical trial and continuing operations.
Cellectar Opens Custom-Designed Radiopharmaceutical Manufacturing Facility for Novel Cancer Therapeutics
December 10, 2007
Cellectar announces the opening of a new, custom-designed radiopharmaceutical manufacturing facility in Madison, Wisconsin.
Cellectar Expands Clinical Management Team
October 3, 2007
Cellectar announces the appointment of Ernest Allen as Director, Clinical Operations and LisaAnn Trembath as Manager, Medical Affairs.
Cellectar Has Strong Showing at Midwest Bio Forum
September 25, 2007
Cellectar President and CEO Bill Clarke attended the Bio Mid-america Venture Forum in Milwaukee this week, and presented Cellectar to a large group of potential investors. Read more in this article from the Milwaukee Journal Sentinel.
Cellectar's Technology Poised For Clinical Trials
August 27, 2007
Cellectar's lead product candidate, CLR1404 is a novel, new molecule that has been shown in preclinical trials to be selectively retained in malignant cells. By attaching a radioactive iodine isotope to CLR1404, Cellectar believes that significant advances in cancer diagnosis and treatment can be achieved. CLR1404 is currently in the preclinical stage and Cellectar plans to move into phase 1 clinical trials in mid-2008.
Attacking Cancer From The Inside
March 11, 2007
Read here for the Wisconsin State Journal article featuring Cellectar.
View Archives
| 
